Found 0 matching trials
A Phase I Trial of Bortezomib and Sunitinib PHASE1 The purpose of this study is to test the effect of the combination of sunit...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma PHASE1 The primary objective of this study is to assess the safety and tolerabilit...
Show More Location
Pacific Oncololgy & Hematology
Learn More & Join Trial
An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma. PHASE2 This is a Phase 1/2 study evaluating the safety and anti-tumor activity of ...
Show More Location
Northwestern Medical Faculty Foundation
Learn More & Join Trial
Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas PHASE1 This phase I trial is studying the side effects and best dose of giving tan...
Show More Learn More & Join Trial
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma PHASE3 Eligible participants with newly diagnosed myeloma who are not considered e...
Show More Location
Gundersen Lutheran
Learn More & Join Trial
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients PHASE3 Multiple myeloma is a malignant incurable hematological disease where survi...
Show More Location
Hæmatologisk afdeling B, Aalborg Sygehus Syd
Learn More & Join Trial
Selinexor, Cyclophosphamide and Prednisone in Myeloma PHASE2 The trial is designed as a randomised, controlled, open, parallel group, mu...
Show More Location
Birmingham Heartlands Hospital
Learn More & Join Trial
Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT PHASE1 Phase I-II studying post transplant cyclophosphamide, bortezomib and sitagl...
Show More Learn More & Join Trial
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia NA This pilot clinical trial studies the feasibility of choosing treatment bas...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL) PHASE1 The purpose of this study is to determine whether the combination of bendam...
Show More Location
Multiple Locations
Learn More & Join Trial